China Life Sciences Conference and Expo 2025

Exhibition Introduction

The 2025 China Life Sciences Conference & Expo (CILSE) will take place from September 26-28, 2025, at the Poly World Trade Center Expo in Guangzhou, China. As one of the most influential global events in life sciences, this expo fosters academic and industrial collaboration across sectors such as biopharmaceuticals, precision medicine, gene therapy, molecular diagnostics, and AI-driven healthcare. Featuring leading scientists, industry pioneers, and cutting-edge innovations, the event integrates academic conferences with exhibitions to drive progress in genomics, synthetic biology, proteomics, immunotherapy, regenerative medicine, and advanced laboratory technologies. Attendees will gain insights into emerging life science trends, R&D breakthroughs, and commercial applications, while exhibitors will have access to top-tier networking, investment opportunities, and global market expansion.

Range of Exhibition

Life Science Reagents & Biotechnology: Research-grade reagents, molecular biology kits, stem cell technologies, bioinformatics, immunoassays, and high-throughput screening services.

Biopharmaceuticals & Regenerative Medicine: Blood-based products, therapeutic antibodies, gene therapy solutions, stem cell & immunotherapy, RNA-based treatments, and vaccine research.

Laboratory Equipment & Consumables: PCR machines, sequencing instruments, centrifuges, incubators, imaging systems, AI-driven lab automation, microfluidics, and high-performance chromatography.

Precision Medicine & Molecular Diagnostics: Genomic sequencing, personalized medicine, liquid biopsy, AI-driven diagnostic imaging, early cancer detection, and epigenetic screening.

Medical Devices & AI in Healthcare: Smart wearables, robotic surgery, real-time health monitoring, digital pathology, AI-powered diagnostics, and big data analytics in medicine.

Synthetic Biology & Biomanufacturing: CRISPR gene editing, metabolic engineering, synthetic protein production, bio-based materials, and industrial fermentation processes.

Omics & Bioinformatics Technologies: Genomics, proteomics, transcriptomics, microbiome analysis, bioinformatics software, cloud-based biological data storage, and AI-assisted molecular modeling.

Pharmaceutical R&D & Drug Discovery: Small-molecule drugs, biologics, cell & gene therapy, high-throughput screening technologies, and AI-driven drug design.

Bioengineering & Bioprocessing: Cell culture systems, bioreactors, fermentation equipment, purification & separation technology, automation in biologics production.

HealthTech & Digital Healthcare Solutions: Telemedicine, electronic health records, blockchain in healthcare, remote patient monitoring, and wearable diagnostic devices.

Target Audience

Biotechnology researchers, pharmaceutical companies, healthcare professionals, genetic and molecular scientists, medical technology developers, clinical laboratory specialists, hospital administrators, AI and big data companies in healthcare, precision medicine specialists, biomedical engineers, academic institutions and universities